| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.15T | 1.06T | 1.07T | 951.88B | 830.24B |
| Gross Profit | 186.17B | 185.77B | 181.97B | 135.71B | 116.89B |
| EBITDA | 147.20B | 115.15B | 126.05B | 86.65B | 82.29B |
| Net Income | 62.01B | 36.33B | 51.45B | 16.00B | 23.35B |
Balance Sheet | |||||
| Total Assets | 992.91B | 913.04B | 933.35B | 865.30B | 859.30B |
| Cash, Cash Equivalents and Short-Term Investments | 131.81B | 118.77B | 146.00B | 105.27B | 109.14B |
| Total Debt | 123.34B | 120.03B | 150.02B | 174.93B | 186.30B |
| Total Liabilities | 377.74B | 324.63B | 366.61B | 378.93B | 396.50B |
| Stockholders Equity | 568.56B | 542.63B | 522.34B | 448.41B | 428.81B |
Cash Flow | |||||
| Free Cash Flow | 74.24B | 33.63B | 81.66B | 7.84B | -24.07B |
| Operating Cash Flow | 131.69B | 92.01B | 128.37B | 53.97B | 27.66B |
| Investing Cash Flow | -49.65B | -71.82B | -40.69B | -31.59B | -59.43B |
| Financing Cash Flow | -70.89B | -50.68B | -53.07B | -28.93B | 2.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥249.40B | 8.52 | ― | 3.36% | 4.38% | 12.45% | |
75 Outperform | ¥442.97B | 14.60 | 6.37% | 2.88% | 1.74% | 19.10% | |
74 Outperform | ¥535.65B | 9.44 | 8.58% | 2.62% | 8.21% | 72.79% | |
70 Outperform | ¥767.01B | 47.60 | 7.20% | 2.41% | 3.37% | -62.36% | |
70 Outperform | ¥401.01B | 12.03 | ― | 1.60% | -0.11% | -21.86% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥385.33B | 17.21 | 3.70% | 3.42% | 4.24% | 39.04% |